Laboratory note
Secretagogue class — assay endpoints (RUO)
GH-axis assay endpoint vocabulary
For laboratory research use only. Not for human or veterinary use, consumption, compounding into a medicine, or injection. Not authorized by Health Canada. Literature on this page is scientific context only. This page is not a licensed drug, a wellness protocol, or a dosing guide. Not a licensed growth-hormone product in Canada.
Published endpoint words help a laboratory read a paper. They are not on-label claims for a research vial.
Endpoint map
GH-release language in the literature covers circulating GH and pulse profiles, and it sits near ipamorelin and GHRH analogues. IGF-I axis language sits near CJC-1295 with DAC and tesamorelin. Receptor-class confirmation is the GHRH receptor versus GHSR distinction across the three catalog secretagogues. Analytical identity is HPLC purity plus mass-spec m/z on any lyophilized lot.
Do not treat a published clinical endpoint as an authorized use for a research-use catalog vial. Email request@ and name the compound.
In this library
Bench reconstitution
Reconstitution belongs on the compound brief. This note does not assign a diluent volume.
Diluent page: bacteriostatic water.
PubMed
Selected literature
- PMID 16352683 (2006) Teichman et al., Journal of Clinical Endocrinology & Metabolism — prolonged GH / IGF-I stimulation by CJC-1295
- PMID 17018654 (2006) Ionescu & Frohman, Journal of Clinical Endocrinology & Metabolism — GH pulsatility under continuous CJC-1295 stimulation
- PMID 9849822 (1998) Raun et al., European Journal of Endocrinology — ipamorelin, the first selective growth hormone secretagogue
- PMID 18057338 (2007) Falutz et al., NEJM — GHRH-analogue metabolic research context (literature only)
Literature is scientific context only. A paper does not make a research vial into a licensed medicine.
Certificate of analysis
Ask request@pharmapeptidesrx.com for the lot-matched COA of a named compound. This page is not a COA and it does not claim stock.
Lab FAQ
Does this hub quote a vial?
No. Email request@pharmapeptidesrx.com and name CJC-1295 with DAC, ipamorelin, or tesamorelin. This page does not claim stock.
Laboratory inquiry
Write request@pharmapeptidesrx.com
Questions about this note go to request@pharmapeptidesrx.com from the laboratory account. Research use only.